Chugai Pharmaceutical Co., Ltd. - Tokio, Japan - bionity.com
文章推薦指數: 80 %
Chugai Pharmaceutical Co., Ltd. 1-1 Nihonbashi-Muromachi 2-Chome, Chuo-ku 103-8324 Tokio Japan. Cellculture:Theopportunitiesandthechallenges Mywatchlist my.bionity.com Withanaccoutformy.bionity.comyoucanalwaysseeeverythingataglance–andyoucanconfigureyourownwebsiteandindividualnewsletter. Mywatchlist Mysavedsearches Mysavedtopics Mynewsletter Registerfreeofcharge Login Keeploggedin Forgotyourpassword? Touseallfunctionsofthispage,pleaseactivatecookiesinyourbrowser. Login Register DeutschEnglishFrançaisEspañol HomeCompaniesChugaiPharmaceuticalCo.,Ltd. Togglenavigation Home News Back News News Newsletters RSS-Feeds Companies&Start-ups Back Companies&Start-ups Companies Start-ups Associations Products Back Products Products MarketOverviewMassSpectrometers MarketOverviewHPLCSystems MarketOverviewParticleSizeAnalyzers MarketOverviewUV-VisSpectrometers MarketOverviewPCRThermocyclers MarketOverviewAutoclaves MarketOverviewFlowCytometers MarketOverviewForeignObjectDetection WebinarLibrary KnowledgeWorlds Back KnowledgeWorlds Whitepapers Publications Lexicon Infographics ResearchInstitutes Videos Career Back Career JobOffers PlaceyourJobAd Jobletter TopicWorlds Back TopicWorlds TopicWorldMassSpectrometry TopicWorldParticleAnalysis TopicWorldChromatography TopicWorldSpectroscopy TopicWorldPCR TradeFairPreviewanalytica2022 ACHEMA2022 Tools DEENFRES Cellculture:Theopportunitiesandthechallenges ChugaiPharmaceuticalCo.,Ltd. Showphonenumber Showwebsite 1-1Nihonbashi-Muromachi2-Chome,Chuo-ku 103-8324Tokio Japan Requestinformationnow Profile News&information Onlocation Profile Facts News&information Currentnews GeneBridgesLicensesRecombineeringTechnologytoChugaiPharmaceuticalCo.,Ltd. GeneBridgesGmbHannouncedthatChugaiPharmaceuticalCo.,Ltd.ofTokyo,Japanhascompletedtheamendmenttoexpandthecommerciallicenseagreementexistingsince2005fortheuseoftheRed/ETrecombinationtechnologyfromGeneBridges.TheRed/ETrecombinationtechnology,patentedin...>more OSIPharmaceuticalsAnnouncesSubmissionofNewDrugApplicationforTarceva(R)inJapan OSIPharmaceuticals,Inc.announcedthataNewDrugApplicationhasbeensubmittedinJapancoveringtheuseofitsflagshipproduct,Tarceva(R)(erlotinib),forthetreatmentofadvancedorrecurrentnon-smallcelllungcancer(NSCLC).TheapplicationwassubmittedtotheJapaneseMinistry...>more CambrexLicensesCellLinetoChugaiPharmaceuticalCo. CambrexBioScienceWalkersville,Inc.,asubsidiaryofCambrex,announcedthatitsclientChugaiPharmaceuticalCo.,Ltd.completedtheirassessmentofcertainofitsClonetics(R)ConditionallyImmortalizedCellLinesunderthepreviouslyannouncedevaluationlicenseandsignedaone-year...>more >AllNews Allcontents News:5 Onlocation Office Requestinformationnow Addcompanytowatchlist Recommendcompany Recommendcompany Shareon Youarecurrentlynotloggedintomy.bionity.com. Yourchangeswillinfactbestoredhowevercanbelostatalltimes. Login Register MoreaboutChugaiPharmaceutical News GeneBridgesLicensesRecombineeringTechnologytoChugaiPharmaceuticalCo.,Ltd. GeneBridgesGmbHannouncedthatChugaiPharmaceuticalCo.,Ltd.ofTokyo,Japanhascompletedtheamendmenttoexpandthecommerciallicenseagreementexistingsince2005fortheuseoftheRed/ETrecombinationtechnologyfromGeneBridges.TheRed/ETrecombinationtechnology,patentedin...more OSIPharmaceuticalsAnnouncesSubmissionofNewDrugApplicationforTarceva(R)inJapan OSIPharmaceuticals,Inc.announcedthataNewDrugApplicationhasbeensubmittedinJapancoveringtheuseofitsflagshipproduct,Tarceva(R)(erlotinib),forthetreatmentofadvancedorrecurrentnon-smallcelllungcancer(NSCLC).TheapplicationwassubmittedtotheJapaneseMinistry...more CambrexLicensesCellLinetoChugaiPharmaceuticalCo. CambrexBioScienceWalkersville,Inc.,asubsidiaryofCambrex,announcedthatitsclientChugaiPharmaceuticalCo.,Ltd.completedtheirassessmentofcertainofitsClonetics(R)ConditionallyImmortalizedCellLinesunderthepreviouslyannouncedevaluationlicenseandsignedaone-year...more MorenewsbyChugaiPharmaceutical TopCompanies 1ShanthaBiotechnicsLtd. 2RanbaxyLaboratoriesLtd. 3LifeTechnologiesCorporation 4IntasBiopharmaceuticalsLtd. 5Epitomics,Inc. 6SynthesGmbH 7MEDAPharmaGmbH&Co.KG 8SPECTROAnalyticalInstrumentsGmbH 9EVIDENTEuropeGmbH 10CytivaEuropeGmbH other TopicsA-Z 0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z Alltopics Aboutbionity.com Readwhatyouneedtoknowaboutourindustryportalbionity.com. findoutmore > AboutLUMITOS FindoutmoreaboutthecompanyLUMITOSandourteam. findoutmore > AdvertisewithLUMITOS FindouthowLUMITOSsupportsyouwithonlinemarketing. findoutmore > TheLUMITOSindustryportals chemie.de chemeurope.com quimica.es bionity.com yumda analytica.world.com q&more
延伸文章資訊
- 1Hiroaki Nagashima - Chugai Pharmaceutical Co., Ltd. | LinkedIn
Hiroaki Nagashima. Manager Process Development - Roche. Chugai Pharmaceutical Co., Ltd.Tokyo Univ...
- 2中外製薬株式会社|創造で、想像を超える。
中外製薬について知るAbout Chugai ... 当社では、利用者の皆さまに本ウェブサイト(www.chugai-pharm.co.jp)を快適にご利用いただくため、また、ソーシャルメディア...
- 3中外製藥- 维基百科,自由的百科全书
總資產, 1兆589億1,500万日元(2019年3月). 員工人數, 6,872 编辑维基数据 · 母公司 · 羅氏(61.62%). 网站, www.chugai-pharm.co.jp ...
- 4Chugai - Roche
Chugai Pharmaceutical Co., Ltd. Chugai Pharmaceutical was founded in ... Chugai has over 7,500 em...
- 5CHUGAI PHARMACEUTICAL CO., LTD. | Member Companies
2-1-1 Nihonbashimuromachi, Chuo-ku, Tokyo 103-8324. Contact. Phone:+81-3-3281-6611. FAX:+81-3-328...